Enterprise Value
$2.05 B
+$79.75 M+4.05%
8 min ago
Summary
- As of March 12, 2025, RXRX enterprise value is $2.05 billion, with a rise of +$79.75 million (+4.05%) during the most recent trading day.
- Over the past year, RXRX enterprise value has dropped by -$98.72 million (-4.59%).
- RXRX enterprise value is now -67.68% below its all-time high of $6.34 billion.
Performance
RXRX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RXRX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +4.0% | +3.3% | +3.3% |
| 1 m1 month | -24.5% | -20.8% | -20.8% |
| 3 m3 months | -16.0% | -8.7% | -11.3% |
| 6 m6 months | +40.0% | +37.2% | -3.7% |
| ytdytd | -7.1% | -5.8% | -7.1% |
| 1 y1 year | -4.6% | +1.9% | -40.5% |
| 5 y5 years | - | - | - |
RXRX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -47.9% | $1.93 B | +6.0% | |
| 3 m | 3-month | $3.94 B | -47.9% | $1.93 B | +6.0% |
| 6 m | 6-month | $3.94 B | -47.9% | $1.41 B | +45.3% |
| 1 y | 1-year | $3.94 B | -47.9% | $1.30 B | +58.0% |
| 3 y | 3-year | $3.94 B | -47.9% | $411 M | +398.6% |
| 5 y | 5-year | $6.34 B | -67.7% | $411 M | +398.6% |
| alltime | all time | $6.34 B | -67.7% | $411 M | +398.6% |
Recursion Pharmaceuticals Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $2.05 B(-7.1%) |
| 2024 | $2.21 B(+10.6%) |
| Date | Value |
|---|---|
| 2023 | $1.99 B(+113.6%) |
| 2022 | $933.76 M(-64.7%) |
| 2021 | $2.64 B |
FAQ
- What is Recursion Pharmaceuticals enterprise value?
- What is the all time high enterprise value for Recursion Pharmaceuticals?
- What is RXRX enterprise value year-to-date change?
- What is Recursion Pharmaceuticals enterprise value year-on-year change?
What is Recursion Pharmaceuticals enterprise value?
The current enterprise value of RXRX is $2.05 B
What is the all time high enterprise value for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high enterprise value is $6.34 B
What is RXRX enterprise value year-to-date change?
Recursion Pharmaceuticals enterprise value has changed by -$156.36 M (-7.09%) since the beginning of the year
What is Recursion Pharmaceuticals enterprise value year-on-year change?
Over the past year, RXRX enterprise value has changed by -$98.72 M (-4.59%)